Keynote & Workshop Topics:
|
Pharmaceuticals
|
The Dangers in Opportunity
|
The pharmaceutical industry faces challenges when it expected opportunities: the rising demand for pharmaceutical products, diagnostics, and tests has brought a faster rising tide of complaints and threats from consumers and governments. At the same time, research pipelines, which were expected to be overflowing from the boom in genetic research and molecular biology, is increasingly struggling to get product to market. Futurist and strategic planner Richard Worzel assesses the prospects ahead, outlining what drug companies can expect in consumer behavior and demands; policies by governments; and developments both in and outside of the pharmaceutical industry that will affect bottom-line profitability. Along the way, he'll discuss the strategies that successful firms will have to adopt if they are to achieve the levels of profitability that should accompany the undoubted opportunities brought by an aging society, and remarkable new research tools.
|
|
| |
| |
|
|
|
